Helena Wilcox
Associate Director, The Health Policy Partnership
Health systems are under growing pressure to improve outcomes amid workforce shortages, rising demand and constrained resources.
New technologies, from AI-enabled diagnostics to digital platforms, offer real opportunities, but technology alone does not transform care. Lasting impact depends on whether systems are equipped to use innovation well.
Too often, implementation focuses on adopting a new tool rather than understanding how it affects the wider patient pathway. Yet, every innovation creates ripple effects. A new diagnostic, for example, may identify more people who need follow-up investigations, treatment or ongoing support. Without sufficient planning, pressure is simply shifted from one part of the pathway to another.
Whole system approach required
Meaningful change requires a whole-system approach before, during and after implementation. Beforehand, health systems must map where capacity is constrained and how demand will change. During rollout, the focus must extend beyond technology to workforce, infrastructure, workflows, data and governance. Afterwards, continuous evaluation shows whether innovation is genuinely delivering value for patients and health services.
To realise the full benefits of screening,
pathways must adapt alongside the technology
Lung cancer screening in England demonstrates why this matters. Screening can detect cancers earlier, when treatment is more effective, and survival improves. However, identifying more people who require assessment inevitably increases demand for imaging, diagnostic services, multidisciplinary teams, surgery and oncology care.
AI screening needs pathway-wide adaptation
To realise the full benefits of screening, pathways must adapt alongside the technology. AI-enabled tools can already help; in a UK lung screening study, an AI ‘first reader’ flagged every confirmed cancer while clearing negative scans, potentially cutting radiologists’ reading workload by up to 79%. Even so, capacity restraints may resurface elsewhere – radiology in some areas, surgery or specialist treatment services in others. Ongoing monitoring and service redesign are essential so that gains in one part of the pathway are not lost in another.
Measure impact, not simply deployment
Most importantly, this is about people, not processes. For patients, better pathways mean faster diagnosis, shorter waits, smoother transitions between services and earlier access to treatment. It matters for staff, too; involving healthcare professionals in how technologies are designed and rolled out makes implementation more effective. As leaders continue to invest in innovation, success should be measured not by the number of technologies deployed, but by whether they help deliver more coordinated and person-centred care.
